뉴스

• BL Pharmtech Shares Hit Upper Limit as Expectations Grow for Technology Transfer Deal[K-Bio Pulse... On June 18, shares of BL PharmTech, JLK, and Raphas stood out in the domestic pharmaceutical and biotechnology stock market with strong gains. In particular, BL www.edaily.co.kr · 2026.06.21
• Remedi Surges 23%; Bio Solution Climbs on China Expansion [K-bio pulse] Portable X-ray maker Remedi saw its shares surge after reporting explosive earnings growth. The company is expanding rapidly not only in South Korea but also overseas, raising expectations for www.edaily.co.kr · 2026.08.19
• Korean Dental Stocks Rally on M&A, Strong Earnings[K-Bio Pulse] Shares of dental-related companies rallied in South Korea's pharmaceutical, biotech and health care market on Aug. 11, buoyed by expectations for business expansion and strong earnings.South Korea's ... www.edaily.co.kr · 2026.08.12
• Cellid Crashes After-Hours on Phase 3 Failure...Shaperon Dives 25%[K-bio pulse] In the biopharmaceutical sector on Friday, Cellid’s stock surged on expectations for its vaccine clinical trial results, but the shares plunged by the daily limit in after-hours trading followi... www.edaily.co.kr · 2026.06.29
• [디엘지 law 인사이트] 지분율, 투자자와 창업자가 다르게 이해할 수 있어 이것이 흔히 말하는 발행주식 기준, 즉 아웃스탠딩 주식(Outstanding Shares) 기준이다.이 기준은 현재 법률상 주주가 누구인지, 의결권과 배당권을 누가 행사하는지 확인하는 미국 VC가 보는 캡테이블은 대체로 완전희석(Fully Diluted Shares) 기준에 가깝다. zdnet.co.kr · 2026.07.14